Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
The Oncologist
|
August 12, 2025
Barriers and Facilitators to Representative Acute Leukemia Trial Participation at National Cancer Institute-Designated Comprehensive Cancer Centers
Andrew Hantel, Eric C Blackstone, Anna C Revette, et al.
Blood
|
April 21, 2012
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia
Josephine Aimiuwu, Hongyan Wang, Ping Chen, et al.
Leukemia Research
|
January 15, 2020
Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia
Caner Saygin, Nicole Grieselhuber, James Blachly, et al.
Journal of Cancer Survivorship : Research and Practice
|
April 28, 2024
Determining the relationship of p16<sup>INK4a</sup> and additional molecular markers of aging with clinical frailty in hematologic malignancy
Ashley E Rosko, Mohamed I Elsaid, Jennifer Woyach, et al.
Frontiers in Oncology
|
January 31, 2022
<i>Post-hoc</i> Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA
Justin Watts, Tara L Lin, Alice Mims, et al.
JAAD Case Reports
|
May 30, 2023
Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil
Ashley N Gray, Christina Avila, Catherine G Chung, et al.
Leukemia & Lymphoma
|
March 28, 2024
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m<i>IDH1</i>) acute myeloid leukemia (AML)
Jorge Cortes, Brian A Jonas, Gary Schiller, et al.
Leukemia & Lymphoma
|
February 19, 2019
HSP90 inhibition depletes DNA repair proteins to sensitize acute myelogenous leukemia to nucleoside analog chemotherapeutics
Tzung-Huei Lai, Shaneice Mitchell, Pei-Jung Wu, et al.
British Journal of Haematology
|
December 19, 2024
Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm
Stéphane De Botton, Christian Récher, Jorge Cortes, et al.
Molecular and Cellular Biology
|
April 30, 2014
The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling
Bo Cen, Ying Xiong, Jin H Song, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
The Oncologist
|
August 12, 2025
Barriers and Facilitators to Representative Acute Leukemia Trial Participation at National Cancer Institute-Designated Comprehensive Cancer Centers
Andrew Hantel, Eric C Blackstone, Anna C Revette, et al.
Blood
|
April 21, 2012
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia
Josephine Aimiuwu, Hongyan Wang, Ping Chen, et al.
Leukemia Research
|
January 15, 2020
Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia
Caner Saygin, Nicole Grieselhuber, James Blachly, et al.
Journal of Cancer Survivorship : Research and Practice
|
April 28, 2024
Determining the relationship of p16<sup>INK4a</sup> and additional molecular markers of aging with clinical frailty in hematologic malignancy
Ashley E Rosko, Mohamed I Elsaid, Jennifer Woyach, et al.
Frontiers in Oncology
|
January 31, 2022
<i>Post-hoc</i> Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA
Justin Watts, Tara L Lin, Alice Mims, et al.
JAAD Case Reports
|
May 30, 2023
Cutaneous graft-versus-host disease within chronic photodamaged skin: A case series demonstrating role for topical 5-fluorouracil
Ashley N Gray, Christina Avila, Catherine G Chung, et al.
Leukemia & Lymphoma
|
March 28, 2024
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m<i>IDH1</i>) acute myeloid leukemia (AML)
Jorge Cortes, Brian A Jonas, Gary Schiller, et al.
Leukemia & Lymphoma
|
February 19, 2019
HSP90 inhibition depletes DNA repair proteins to sensitize acute myelogenous leukemia to nucleoside analog chemotherapeutics
Tzung-Huei Lai, Shaneice Mitchell, Pei-Jung Wu, et al.
British Journal of Haematology
|
December 19, 2024
Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm
Stéphane De Botton, Christian Récher, Jorge Cortes, et al.
Molecular and Cellular Biology
|
April 30, 2014
The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling
Bo Cen, Ying Xiong, Jin H Song, et al.
Page
of 5